N.J. Legakis
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 86
- Endocrinology top 0.2%
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 20
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 22
-
- Antibiotics Pharmacokinetics and Efficacy 28
-
- Bacterial biofilms and quorum sensing 27
-
- Pneumonia and Respiratory Infections 26
-
- Salmonella and Campylobacter epidemiology 16
-
- Streptococcal Infections and Treatments 14
- Co-authors
- L. S. TzouvelekisPanayotis T. TassiosΕva TzelepiAthanasios TsakrisAlkiviadis VatopoulosPatricia WinokurRafael CantónAristea Velegraki
- Journals
- Journal of Clinical Microbiology (21 papers)Clinical Microbiology and Infection (19 papers)Journal of Antimicrobial Chemotherapy (17 papers)
- Partner nations
- GreeceUnited StatesFrance
In The Last Decade
N.J. Legakis
183 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 127
- Molecular Medicine 2.6k
- Applied Microbiology and Biotechnology 499
- Endocrinology 1.1k
- Clinical Biochemistry 411
- Infectious Diseases 973
Countries citing papers authored by N.J. Legakis
This map shows the geographic impact of N.J. Legakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.J. Legakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.J. Legakis more than expected).
Fields of papers citing papers by N.J. Legakis
This network shows the impact of papers produced by N.J. Legakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.J. Legakis. The network helps show where N.J. Legakis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N.J. Legakis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 10 | |
| 2 | 2004 | 85 | |
| 3 | 2003 | 62 | |
| 4 | 2003 | 9 | |
| 5 | 2003 | 10 | |
| 6 | 2003 | 17 | |
| 7 | 2002 | 83 | |
| 8 | 2001 | 41 | |
| 9 | 2001 | 17 | |
| 10 | 2001 | 33 | |
| 11 | 1999 | 5 | |
| 12 | 1999 | 10 | |
| 13 | 1999 | 26 | |
| 14 | 1998 | 1 | |
| 15 | 1998 | 3 | |
| 16 | 1998 | 24 | |
| 17 | 1997 | 7 | |
| 18 | 1996 | 14 | |
| 19 | 1995 | 5 | |
| 20 | 1990 | 75 |
About N.J. Legakis
N.J. Legakis is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Endocrinology, having authored 187 papers that have together received 5.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (86 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers), Bacterial biofilms and quorum sensing (27 papers), Pneumonia and Respiratory Infections (26 papers), Antimicrobial Resistance in Staphylococcus (22 papers), Bacterial Identification and Susceptibility Testing (20 papers), Salmonella and Campylobacter epidemiology (16 papers) and Streptococcal Infections and Treatments (14 papers). The work is most often cited by research in Molecular Medicine (2.6k citations), Applied Microbiology and Biotechnology (499 citations) and Endocrinology (1.1k citations). N.J. Legakis has collaborated with scholars based in Greece, United States and France. Frequent co-authors include L. S. Tzouvelekis, Panayotis T. Tassios, Εva Tzelepi, Athanasios Tsakris, Alkiviadis Vatopoulos, Patricia Winokur, Rafael Cantón, Aristea Velegraki, Antonios N. Maniatis and Vivì Miriagou. Their work appears in journals such as Journal of Clinical Microbiology, Clinical Microbiology and Infection, Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.